ADHD and Menopause
Many women with AD/HD report an increase in AD/HD symptoms when they enter perimenopause and menopause. Medications that were once effective for AD/HD may not work as well. Estrogen influences neurotransmitter systems and the levels of neurotransmitters (dopamine, norepinephrine, and serotonin) involved with AD/HD as well as depression and anxiety.
Someone with AD/HD already has dysfunction of neurotransmitter systems in the brain, which are only magnified when estrogen levels begin to fall in the perimenopausal period causing further dysfunction. Many women complain of memory problems, mood changes (sad, irritable, worried), hot flashes, sleep problems, memory problems, and problems with mental clarity during the years prior to the onset of menopause, which add to symptoms related to AD/HD.
Some women report increased symptoms of AD/HD during any low estrogen state: with increased hormonal fluctuations when girls enter puberty, in the premenstrual period, the postpartum period, and with the onset of menopause, and may report a decrease in AD/HD symptoms during pregnancy and while nursing, when estrogen levels are high. To make matters worse, some women with AD/HD entering perimenopause have a teenage daughter with AD/HD entering puberty!
Comprehensive treatments are often indicated for women with AD/HD whose symptoms are increasing during the perimenopausal period and during menopause.
Sometimes an increase in stimulant medications is effective, but sometimes it is not as some studies have found the response of stimulants to be related to estrogen levels (a better response with higher estrogen levels). Sometimes, estrogen replacement is beneficial, especially in women who not only have a worsening of AD/HD symptoms, but a significant worsening of mood.
However, risks versus benefits must be considered with estrogen replacement. Since falling estrogen levels influences the neurotransmitter serotonin, SSRI antidepressants that increase serotonin are often helpful for depression and anxiety (which can increase inattention and distractibility).
In summary, treatment of increased symptoms of AD/HD during the menopausal period often consists of some combination of a stimulant medication, an SSRI antidepressant, and sometimes short-term estrogen replacement. There are many other things to do about symptoms related to menopause which can be found on WebMD and on www.healthewomen.com.
It's extremely important for women with AD/HD to find a physician who is not only knowledgeable about AD/HD, but is knowledgeable about AD/HD in women.
Dr. Richard Sogn
Related Topics: WebMD Video: Menopause Myths, WebMD Video: Is it ADHD or Vision Problems?
Technorati Tags: ADD, ADHD, AD/HD, menopause, perimenopause
Someone with AD/HD already has dysfunction of neurotransmitter systems in the brain, which are only magnified when estrogen levels begin to fall in the perimenopausal period causing further dysfunction. Many women complain of memory problems, mood changes (sad, irritable, worried), hot flashes, sleep problems, memory problems, and problems with mental clarity during the years prior to the onset of menopause, which add to symptoms related to AD/HD.
Some women report increased symptoms of AD/HD during any low estrogen state: with increased hormonal fluctuations when girls enter puberty, in the premenstrual period, the postpartum period, and with the onset of menopause, and may report a decrease in AD/HD symptoms during pregnancy and while nursing, when estrogen levels are high. To make matters worse, some women with AD/HD entering perimenopause have a teenage daughter with AD/HD entering puberty!
Comprehensive treatments are often indicated for women with AD/HD whose symptoms are increasing during the perimenopausal period and during menopause.
Sometimes an increase in stimulant medications is effective, but sometimes it is not as some studies have found the response of stimulants to be related to estrogen levels (a better response with higher estrogen levels). Sometimes, estrogen replacement is beneficial, especially in women who not only have a worsening of AD/HD symptoms, but a significant worsening of mood.
However, risks versus benefits must be considered with estrogen replacement. Since falling estrogen levels influences the neurotransmitter serotonin, SSRI antidepressants that increase serotonin are often helpful for depression and anxiety (which can increase inattention and distractibility).
In summary, treatment of increased symptoms of AD/HD during the menopausal period often consists of some combination of a stimulant medication, an SSRI antidepressant, and sometimes short-term estrogen replacement. There are many other things to do about symptoms related to menopause which can be found on WebMD and on www.healthewomen.com.
It's extremely important for women with AD/HD to find a physician who is not only knowledgeable about AD/HD, but is knowledgeable about AD/HD in women.
Dr. Richard Sogn
Related Topics: WebMD Video: Menopause Myths, WebMD Video: Is it ADHD or Vision Problems?
Technorati Tags: ADD, ADHD, AD/HD, menopause, perimenopause


